Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A role for Apolipoprotein A-I in the pathogenesis of multiple sclerosis.
Predictive Value of Baseline Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS) Assessments for Identifying Risk of Prospective Reports of Suicidal Behavior During Research Participation.
Anti-CCP Antibody Levels Are Not Associated with MS: Results from a Case-Control Study.
Measuring Gray Matter and White Matter Damage in MS: Why This is Not Enough.
Possible new modifications for the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis.
Application of the 2010 revised criteria for the diagnosis of multiple sclerosis to patients with clinically isolated syndromes.
Systematic Review of the Epidemiology of Urinary Incontinence and Detrusor Overactivity among Patients with Neurogenic Overactive Bladder.
Cutting-edge of advanced MRI for demyelinating diseases.
Thalamo-striato-cortical determinants to fatigue in multiple sclerosis.
Spasticity treatment with onabotulinumtoxin A: data from a prospective German real-life patient registry.
Deficient Natural Killer Dendritic Cell Responses Underlay the Induction of Theiler's Virus-Induced Autoimmunity.
Retinal ganglion cell layer thinning within one month of presentation for optic neuritis.
Challenges in randomized controlled trials and emerging multiple sclerosis therapeutics.
Dissecting the role of E2 protein domains on alphavirus pathogenicity.
IL-21R signaling is critical for induction of spontaneous experimental autoimmune encephalomyelitis.
IL-1β Is Involved with the Generation of Pain in Experimental Autoimmune Encephalomyelitis.
RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
Nongenomic actions of neurosteroid pregnenolone and its metabolites.
A tetramethoxychalcone from Chloranthus henryi suppresses lipopolysaccharide-induced inflammatory responses in BV2 microglia.
The Case | The young philosopher with multiple sclerosis and proteinuria.
Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy.
Uptake and presentation of myelin basic protein by normal human B cells.
[Clinical features of 314 patients with relapsing-remitting multiple sclerosis].
Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of Multiple Sclerosis.
Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica.
Pages
« first
‹ previous
…
638
639
640
641
642
643
644
645
646
…
next ›
last »